ATRIN PHARMACEUTICALS is a pharmaceuticals company based out of 1040 GLENDEVON DR, AMBLER, Pennsylvania, United States. Founded in 2011, the company operates within the Biotechnology and Pharmaceutical industries. ATRIN PHARMACEUTICALS recently received their Series A investment on 02 July 2022, with Keiretsu Capital as the investors. This signals a noteworthy milestone for the company, indicating its potential for growth and innovation in the pharmaceutical sector. With its strategic location and focused investment, ATRIN PHARMACEUTICALS is poised to make significant strides in the medical field.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series A | Unknown | 1 |
|
02 Jul 2022 |
| Venture Round | Unknown | 1 |
|
11 May 2022 |
| Convertible Note | $150.00K | 2 |
|
01 Feb 2019 |
| Grant | $300.00K | 1 | National Cancer Institute | 19 Oct 2016 |
| Venture Round | $1.23M | - | 01 Apr 2016 |
We care about your data, and we'd love to use cookies make your experience better.
